Abstract
Toxification of benzylic alcohols (e.g. hydroxymethylpyrenes) by sulfotransferases is efficiently competed by alcohol dehydrogenases (ADHs). We are interested in drugs and food constituents affecting this detoxification. Daidzein and cimetidine were reported to inhibit ADH1C-mediated ethanol oxidation. Surprisingly, we found that both modulators enhance the oxidation of 4-hydroxymethylpyrene by ADH1C. This activation was seen with either delivering solvents used, dimethylsulfoxide or acetonitrile. Addition of dimethylsulfoxide, but not acetonitrile, converted daidzein and cimetidine from inhibitors to activators of the ADH1C-mediated oxidation of the other substrate studied, ethanol (added in water). Other human ADH forms (ADH2, 3, 4) were inhibited by both agents independently of the substrate and the corresponding solvent used. Kinetic constants for the various reactions are presented. ADH1C was unique in its complex substrate-dependent interaction with daidzein/cimetidine and solvents.
Keywords: ADH1C, cimetidine, daidzein, hydroxymethylpyrene, enzyme inhibition, enzyme activation.
Drug Metabolism Letters
Title:Opposing – Activating or Inhibitory – Effects of Cimetidine and Daidzein on Human ADH1C Activity Depending on Substrates and Solvents
Volume: 6 Issue: 4
Author(s): Ronny Kollock and Hansruedi Glatt
Affiliation:
Keywords: ADH1C, cimetidine, daidzein, hydroxymethylpyrene, enzyme inhibition, enzyme activation.
Abstract: Toxification of benzylic alcohols (e.g. hydroxymethylpyrenes) by sulfotransferases is efficiently competed by alcohol dehydrogenases (ADHs). We are interested in drugs and food constituents affecting this detoxification. Daidzein and cimetidine were reported to inhibit ADH1C-mediated ethanol oxidation. Surprisingly, we found that both modulators enhance the oxidation of 4-hydroxymethylpyrene by ADH1C. This activation was seen with either delivering solvents used, dimethylsulfoxide or acetonitrile. Addition of dimethylsulfoxide, but not acetonitrile, converted daidzein and cimetidine from inhibitors to activators of the ADH1C-mediated oxidation of the other substrate studied, ethanol (added in water). Other human ADH forms (ADH2, 3, 4) were inhibited by both agents independently of the substrate and the corresponding solvent used. Kinetic constants for the various reactions are presented. ADH1C was unique in its complex substrate-dependent interaction with daidzein/cimetidine and solvents.
Export Options
About this article
Cite this article as:
Kollock Ronny and Glatt Hansruedi, Opposing – Activating or Inhibitory – Effects of Cimetidine and Daidzein on Human ADH1C Activity Depending on Substrates and Solvents, Drug Metabolism Letters 2012; 6 (4) . https://dx.doi.org/10.2174/1872312811206040005
DOI https://dx.doi.org/10.2174/1872312811206040005 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Multiple Roles of Transient Receptor Potential (TRP) Channels in Inflammatory Conditions and Current Status of Drug Development
Current Topics in Medicinal Chemistry New Molecules and Strategies in the Field of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Current Cancer Drug Targets A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis
Current Pharmaceutical Design Epidemiology and Pathophysiology of Chronic Cough
Current Respiratory Medicine Reviews Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Effects of Iron Chelation in Osteosarcoma
Current Cancer Drug Targets TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis of Biologically Active Selenium-Containing Molecules From Greener Perspectives
Current Green Chemistry The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art
Current Cancer Therapy Reviews Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Metabolic Transformation and Mechanism of Action of Mononitroso Caffeidine- A New Interpretation
Endocrine, Metabolic & Immune Disorders - Drug Targets An Interventional Pulmonologist’s Tool: Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Thoracic Disease — An Update
Current Respiratory Medicine Reviews Advances in Photodynamic Therapy of Cancer
Current Cancer Therapy Reviews